At the end of January, a team of chemists and engineers left Aberdeen Proving Ground for the Mediterranean Sea to lead the historic destruction of Syria's chemical weapons. More than two months later, they're still waiting for the mission to start.
A team of civilian specialists from Aberdeen Proving Ground is heading this week to the Mediterranean Sea for what officials and others say is a historic mission to destroy Syria's chemical warfare stockpile – and one that could serve as a model in the drive to rid the world of weapons of mass destruction.
Rockville biotechnology company Emergent BioSolutions Inc. has struck a deal to buy Canadian firm Cangene Corp., which employs 100 people in Baltimore, for $222 million in cash, the companies said Thursday.
The Organization for the Prohibition of Chemical Weapons already won the Nobel Peace Prize for its efforts to strip Syria of its stockpile of chemical weapons. But carrying out the process is a complex feat of chemistry – one that could require the help of a team of scientists at Aberdeen Proving Ground.
Smiths Detection, which makes detectors locally and overseas that are small enough to take into the field, said it has spotted its units used in Syria as international peacekeepers search for more details about attacks that killed civilians in the war-torn country.
WASHINGTON -- The dean of Maryland's congressional delegation emerged from a classified briefing Thursday persuaded that Syrian leader Bashar Assad was responsible for last month's chemical weapons attack but undecided on whether a U.S. military strike is the best response.
Several dozen protesters rallied in Rockville and Ellicott City on Wednesday to deliver the message that even in Democratic Maryland — where six in 10 voted to re-elect President Obama last year — there are deep misgivings about U.S. involvement in another Middle East war.
Members of Maryland's congressional delegation said Saturday they welcome a debate on whether the U.S. should launch a military strike against Syria but said they want to review classified intelligence reports — and hear about the scope of President Barack Obama's plan — before deciding whether to sign off.